Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccine regimen plus Ad26.ZEBOV booster at 1 year versus 2 years in health-care and front-line workers in the Democratic Republic of the Congo : secondary and exploratory outcomes of an open-label, randomised, phase 2 trial
Source
The lancet infectious diseases - ISSN 1473-3099- (2024) p. 1-14
Longitudinal assessment of an Ebola vaccine trial understanding among healthcare providers in the Democratic Republic of the Congo
Source
Vaccine - ISSN 0264-410X-42:3 (2024) p. 481-488
Conducting an Ebola vaccine trial in a remote area of the Democratic Republic of the Congo : challenges, mitigations, and lessons learned
Source
Vaccine - ISSN 0264-410X-41:51 (2023) p. 7587-7597
Researchers’ responsibilities in resource-constrained settings : experiences of implementing an ancillary care policy in a vaccine trial in the Democratic Republic of the Congo
Source
Research Ethics - ISSN 1747-0161- (2023) p. 1-17
Setting-up an Ebola vaccine trial in a remote area of the Democratic Republic of the Congo : challenges, mitigations, and lessons learned
Source
Vaccine - ISSN 0264-410X-40:25 (2022) p. 3470-3480